Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.62%195.301.2%$554.29m
TSROTESARO, Inc.
0.11%74.1714.4%$549.90m
CELGCelgene Corporation
0.29%68.881.2%$526.64m
GILDGilead Sciences, Inc.
0.16%67.600.9%$514.07m
BIIBBiogen Inc.
0.18%320.001.3%$360.16m
ILMNIllumina, Inc.
1.33%327.343.5%$358.96m
REGNRegeneron Pharmaceuticals, Inc.
-0.36%376.222.6%$260.58m
VRTXVertex Pharmaceuticals Incorporated
-0.58%172.771.9%$240.46m
AAgilent Technologies, Inc.
0.65%71.051.5%$239.09m
ALXNAlexion Pharmaceuticals, Inc.
-0.30%114.312.0%$141.83m
SRPTSarepta Therapeutics, Inc.
0.99%124.0215.4%$115.26m
INCYIncyte Corporation
-0.12%65.342.5%$106.29m
EXASExact Sciences Corporation
0.12%69.6325.3%$102.01m
NKTRNektar Therapeutics
-1.47%36.125.5%$98.59m
EXELExelixis, Inc.
-1.29%21.096.4%$83.84m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.